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ABSTRACT 
Angiogenesis, the formation of new vessels, is one of the key mechanisms in tumor development and 
an appealing target for therapy. Non-invasive, high-resolution, high sensitivity, quantitative 3D imaging 
techniques are required to correctly depict tumor heterogeneous vasculature over time. Ultrafast Doppler 
was recently introduced and provides an unprecedented combination of resolution, penetration depth 
and sensitivity without requiring any contrast agents. The technique was further extended to 3D with 
Ultrafast Doppler Tomography (UFD-T). In this work, UFD-T was applied to the monitoring of tumor 
angiogenesis in vivo providing structural and functional information at different stages of development. 
UFD-T volume renderings showed that our murine model’s vasculature stems from pre-existing vessels 
and sprouts to perfuse the whole volume as the tumor grows until a critical size is reached. Then, as the 
network becomes insufficient, the tumor core is no longer irrigated because the vasculature is mainly 
concentrated in the periphery. In addition to spatial distribution and growth patterns, UFD-T allowed a 
quantitative analysis of vessel size and length, revealing that the diameter-distribution of vessels 
remained relatively constant throughout tumor growth. The network is dominated by small vessels at all 
stages of tumor development with more than 74% of the vessels less than 200 µm in diameter. This study 
also showed that cumulative vessel length is more closely related to tumor radius than volume, indicating 
that the vascularization becomes insufficient when a critical mass is reached. UFD-T was also compared 
with dynamic contrast-enhanced ultrasound (DCE-US) and shown to provide complementary information 
regarding the link between structure and perfusion. In conclusion, UFD-T is capable of an in vivo 
quantitative assessment of the development of tumor vasculature (vessels with blood speed >1mm/s 
(sensitivity limit) assessed with a resolution limit of 80 µm) in 3D. The technique has very interesting 
potential as a tool for treatment monitoring, response assessment and treatment planning for optimal 
drug efficiency. 
INTRODUCTION 
In 1971, Judah Folkman first introduced the idea that tumor growth was angiogenesis-dependent and 
that this mechanism was a potential target for anti-tumor therapy (Folkman 1971). Indeed, since the 
oxygen diffusion limit is approximately 250 µm,  a tumor cannot exceed a few millimeters in size without 
a blood supply from its own micro-vascular system providing the essential nutriments and oxygen (Cao 
and Langer 2008). The initial hypothesis that tumor cells can secrete growth factors to induce sprouting 
of new blood vessels in their local environment was comforted by numerous studies over the two 
following decades (Folkman 1990). Remarkably, Folkman envisioned from the beginning, the therapeutic 
potential of such a mechanism: inhibition of the tumor’s blood vessel network would both prevent the 
increase of the tumor size and potential metastatic dissemination. An exponential number of studies were 
then conducted to understand the molecular mechanisms of angiogenesis and identify therapeutic targets 
to fight tumor growth (Weis and Cheresh 2011).  
Numerous authors also underlined the heterogeneity and sometimes the inefficiency of the vascular 
network developed by the tumor (Carmeliet and Jain 2000; Dvorak 1986; Folkman 1995; Weis and 
Cheresh 2011). Tumor vascular architecture is chaotic and the blood vessels are structurally and 
functionally anomalous with excessive branching and shunts. From a therapeutic point of view, this poor 
perfusion reduces efficiency of both chemotherapy and radiotherapy. Many preclinical and clinical trials 
for antiangiogenic treatments turned out to be disappointing, with the development of a resistance to 
the treatment or the increased tumor aggressiveness after an initial, slight resorption (Bergers and 
Hanahan 2008; Ellis and Hicklin 2008). However, another interesting effect was discovered. Under certain 
conditions, anti-angiogenic treatments could ‘normalize’ the vascular network of the tumor (Jain 2001), 
leading to a better physiological condition of the tumor and an increased sensitivity to cytotoxic therapies. 
New therapeutic strategies were then developed relying on the combined use of anti-antiangiogenics and 
radiotherapy or chemotherapy (Jain et al. 2011). A very exhaustive review of these strategies has been 
given by Goel et al (Goel et al. 2011). 
Studies have also shown that heterogeneous tumor vascularization both in structure and function can 
be associated with disease progression and malignancy (Agrawal et al. 2009). Indeed aberrant vascular 
regions of metabolic insufficiency, ischemia, and necrosis are commonly found in growing tumors 
(Gilbertson and Rich 2007). The paradox of reduced vascularization leading to increased tumor growth 
rate was thoroughly investigated (Carmeliet et al. 1998) and led to the discovery of the Hypoxia-inducible 
factor-1 (HIF-1), an angiogenesis promoter activated when oxygen levels are substantially reduced 
(Semenza 2003).  The process ultimately results in the selection of the most vigorous, less vascular-
dependent tumor cells (Nagy et al. 2010; Yu et al. 2001). These observations imply that tumor vascular 
heterogeneity may be of interest during diagnosis to anticipate tumor progression in addition to being 
highly relevant in therapy for efficient response assessment and treatment planning.  
In this context, an imaging modality giving both a precise delineation of the tumor vascular bed and 
information on the local hemodynamics with high spatial and temporal resolution would be very 
beneficial for preclinical and clinical imaging. The assessment of the structural and functional organization 
is of the highest interest to study the dynamics of the formation of new vascular networks and to monitor 
their normalization when anti-angiogenics are administered. Imaging modalities such as µCT or MRI 
enable 3D imaging with quite high spatial resolution and very good tissue penetration (de Jong et al. 2014). 
However, their usefulness to evaluate the vascular system remains limited for repeated tumor monitoring 
due to the need for contrast agent injection and ionizing rays (Kiessling et al. 2004). Furthermore, µCT and 
MRI do not provide blood flow dynamics, at least not at the single cardiovascular cycle scale. Indirect 
parameters linked to the time of arrival of the contrast agent can be calculated, but the link with vascular 
architecture and vessel density is not always obvious (Dighe et al. 2013). Optical techniques, of course, 
provide better spatial resolutions but with very limited penetration depths, and fields of view are 
generally limited such that only very small tumors or parts of tumors can be imaged in a reasonable time 
(Vakoc et al. 2009). A particularly interesting technique is photoacoustic imaging due to the penetration 
depth of the ultrasound and optical absorption contrasts (Yao and Wang 2014). A non-exhaustive but 
representative panel of current techniques applied for in vivo tumor imaging is given in Table 1.  
In this imaging landscape, assessment of tumor angiogenesis via ultrasound is currently contingent on 
the use of contrast agent (Payen et al. 2015) or very high frequencies (40 to 100MHz) (Ferrara et al. 2000) 
because conventional ultrasound Doppler techniques suffer from a lack of sensitivity and from the 
impossibility to extract very slow blood flow (below 10 mm.s-1). The recently introduced Ultrafast Doppler 
technique (Bercoff et al. 2011) can resolve both issues by increasing the sensitivity to blood motion 
detection by a factor 50 (Macé et al. 2013) compared to conventional techniques and by enabling new 
paradigms for discrimination between tissue and blood signal using spatiotemporal information (Demené 
et al. 2015). This gives an unprecedented combination of resolution (in-plane 100 µm at an emission 
frequency of 15MHz), sensitivity (x50) and detection of slow blood flow (down to 1 mm.s-1) for a 2D 
vascular imaging modality. This has further been extended to 3D with the invention of UltraFast Doppler 
Tomography (UFD-T), with a first proof of concept made by imaging the rat brain microvasculature 
(Demené et al. 2016).  
In this study, we show that UFD-T is capable of in vivo microvascular imaging of tumor development, 
giving access to high-resolution, quantitative anatomical and functional information in the context of 
angiogenesis monitoring. In particular, vessel size distribution in the tumor was studied to analyze the 
development of the vascular tree. Furthermore, by giving a volumic description of the tumor in its 
entirety, UFD-T overcomes a major pitfall of 2D ultrasound imaging since arbitrary selection of the imaging 
plane is avoided to provide more relevant and reproducible evaluation of the whole tumor. 
MATERIALS AND METHODS 
1.1 Animal protocol 
All animal manipulations have been approved by the French Agriculture Ministry (protocol n° 
Ce5/2012/082) and the local ethics committee. Mouse Lewis lung carcinoma (3LL) cells (ATCC, Manassas, 
VA, USA) were injected (2x105 cells in 100 µL of culture medium) in the flank of a C57BL6 mice (Janvier, 
Le Genest-St-Isle, France). When the lesion reached approximately 300 mm3, the mouse was euthanized 
and the tumors was extracted and fragmented. At Day 0, tumor fragments (~10 mm3) were then 
implanted subcutaneously in the right flank of four, six-week-old female C57BL6 mice (Figure 1). On Days 
8, 12, 16 and 20, UFD-T data were acquired on the tumor of each mouse. Mice were placed on a heating 
pad and flank skin position was maintained using medical adhesive tape to mitigate respiration motion 
artefacts. 
1.2 Ultrafast Doppler Tomography 
UFD-T was performed using an Aixplorer ultrasound scanner (Supersonic Imagine, France) (Figure 1), 
with custom-dedicated software enabling programmable transmission and reception of plane waves. A 
high frequency ultrasonic probe (128 elements, 0.08mm pitch, 15MHz central frequency, 85% bandwidth; 
Vermont, France) was mounted on a custom-motorized set up enabling three degrees of translation (uni-
directional repeatability 0.8 µm, bi-directional repeatability ±10 µm; VT-80, Physik Instrumente (PI), 
Germany) and one degree of rotation (uni-directional repeatability 0.01°, bi-directional repeatability 
±0.2°; DT-80, PI). This set-up defined a coordinate system for the mobile probe with a 3-axes (𝑥′, 𝑦′, 𝑧′) 
(figure 1) coordinate framework: the x’-axis being the dimension along the piezo elements, the z’-axis 
beng the axis of ultrasound propagation, and the y’-axis being the out-of-probe-plane direction (Figure 
1).It enabled acquisition of UFD images in any zOx imaging plane. Acoustic contact was provided by a large 
amount of acoustic gel on and around the tumor beneath a water-filled acoustic tank within which the 
ultrasonic probe could move freely. To reconstruct a 3D volume with a good isotropic resolution despite 
the natural poor elevation focusing capability of the ultrasonic probe, the strategy is to scan the whole 
volume with different angular probe orientations (Demené et al. 2016). For a given orientation θ (see 
Figure 1, θ is the angle 𝑥𝑂𝑥′̂ ) of the probe, a volume is acquired slice by slice by translating the probe 
every 200 µm along y’. Then the probe is rotated along θ with 10° steps, giving a total of 18 scan volumes 
that are then merged in a post-processing step. Depending on the size of the region of interest, the 
number of translations is adapted. A typical 52-step scan provides a 10.4-mm-wide square in the 
horizontal (xOy) orientation. Depth is only limited by absorption of ultrasound and can be up to 25 mm 
with 15 MHz transmit frequency. The scan volume was 10.4x10.4x(12 to 18) mm  because this is the 
maximum volume requiring only one scan for each 𝜃 direction. Because the probe is 128 elements x0.08 
mm = 10.24 mm wide, the scan along the y-direction cannot be longer than 10.24 mm without losing the 
overlap between the scanned volumes. With a 0.2mm scan step, we chose to stop the y’ scanning when 
10.4 mm was reached. For each slice (a plane position parallel to x’0y’), UFD data consists of 400 ultrasonic 
frames (each frame being made of 8 compounded, in phase quadrature beamformed ultrasonic images 
obtained via plane-wave-emissions with different angles (angles -7° to 7° with a 2° step relative to 
horizontal) (Montaldo et al. 2009)), are acquired at a frame rate of 500 Hz (the pulse repetition frequency 
PRF is then 4000 Hz). Respiratory and cardiac gating are performed on each acquisition to avoid 
respiratory artefacts and to ensure that three synchronized cardiac cycles are included in the analyzed 
data. Each UFD dataset is then filtered using a dedicated spatiotemporal Singular Value Decomposition 
filter whose implementation is decribed in Demené et al. (2015), and the energy is computed in each pixel 
to obtain a classical UFD Power image. The complete data set consists of 18 UFD Power volumes (one 
volume representing 52 slices) which are co-registered using correlation techniques and summed. The 3D 
Point Spread Function (PSF) of this entire imaging scheme is simulated using Field II software (Jensen 
2010). To sum up, a linear array with acoustic caracteristics similar to the one used in the experiment has 
been designed for simulation in Field II (128 elements, 0.08mm pitch, 15MHz central frequency, 85% 
bandwidth, elevation width 1.1 mm, elevation focus 5 mm). This linear array was then used to scan across 
the elevation direction for a point source placed at the focus, with simulation of RF Data for the 8 angles 
of plane wave emission described previously. The resulting RF data were beamformed with the same 
beamformer as applied to the real data (delay and sum beamformer, f/d = 1) and the image obtained was 
displayed in terms of the power (square of the amplitude). Then the longitudinal scans were rotated using 
18 angles (10° steps) to emulate the real scanning process, and summed to generate the 𝑝𝑠𝑓(𝑥, 𝑦, 𝑧) of 
our system. This PSF was then used as a deconvolution kernel in a  3D Wiener filter enabling recovery of 
the resolution lost during the averaging process (back to 80 µm). In brief, a Wiener filter ?̂?(𝑘𝑥, 𝑘𝑦, 𝑘𝑧) is 
designed in k-space (being the reciprocal space of the fixed coordinate system (𝑥, 𝑦, 𝑧) of  figure 1) based 
on the input signal Fourier energy spectrum 𝑺(𝑘𝑥 , 𝑘𝑦, 𝑘𝑧), the variance of the noise 𝜎
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and 𝑃𝑆𝐹(𝑘𝑥, 𝑘𝑦, 𝑘𝑧) the Fourier transform of 𝑝𝑠𝑓(𝑥, 𝑦, 𝑧)  obtained in the previously described 
simulation process.  
?̂?(𝑘𝑥, 𝑘𝑦, 𝑘𝑧) =
1
𝑃𝑆𝐹(𝑘𝑥 , 𝑘𝑦, 𝑘𝑧)
.
𝑺(𝑘𝑥, 𝑘𝑦, 𝑘𝑧) − 𝜎
2
𝑺(𝑘𝑥 , 𝑘𝑦, 𝑘𝑧)
 (1)  
The filtered UFD-T volume ?̂?(𝑥, 𝑦, 𝑧) was ultimately computed as follows: 
?̂?(𝑥, 𝑦, 𝑧) = TF−1[?̂?(𝑘𝑥, 𝑘𝑦, 𝑘𝑧). 𝑆(𝑘𝑥, 𝑘𝑦, 𝑘𝑧)] (2)   
A complete and detailed description of the implementation of this 3D reconstruction and filtering 
process can be found in (Demené et al. 2016). 
The spatial variation of the PSF is not taken into account, and cannot be using a Wiener filtering 
formalism since it is based on convolution. We can, therefore, expect better quality around the elevation 
focus. However it should be noted  that the shape of the 3D PSF is mainly driven by the scanning process, 
which is similar across space and only marginally driven by the spatial variations of the in-plane ultrasonic 
PSF of the beamforming process. 
The reconstructed volumes were then rendered and processed using Amira® software (Thermo Fisher 
Scientific, Waltham, Massachusetts, USA). Amira® is a data visualization software enabling volume 
rendering and proposing 3D algorithms and quantification tools. Length and diameter of vessels across 
the vascular network of each tumor were calculated using the skeletonisation tool. For such an algorithm 
to work, a minimum signal threshold has to be defined for a voxel to be considered to be within a vessel. 
This level was set as a z-score (>3𝜎, 𝜎 being the standard deviation of spatial noise). The skeletonisation 
typically performs a medial axis transform to return the center line of each vessel (Lee 1982).The 
skeletonisation then returns the list of all vessel segments with their lengths and mean diameters. This 
population of vessels can then be gathered into 0.04mm-wide diameter bins to calculate the total length 
of sub-populations of vessels with a particular average diameter (Figure 5 and Figure 6). Angiogenesis 
being the physiological process through which new blood vessels form from pre-existing vessels, a 
quantification of angiogenesis needs to put a number on this vasculature, for example the partial volume 
it represents in the tumor. Blood vessels being in first approximation cylindrical, representing their length 
according to their diameter gives both an indication of that volume and of the repartition of blood vessels 
between big and small vessels. 
 
1.3 Dynamic Contrast-Enhanced Ultrasound (DCE-US) 
Contrast imaging was performed after the UFD-T experiments to avoid MB interference in the UFD-T 
results. SonovueTM microbubbles (Bracco Suisse, Geneva, Switzerland) were used for the assessment of 
vascularization (Figure 1). Before use, the contrast agents were reconstituted in 0.9% saline solution, 
resulting in a microbubble (MB) suspension containing 2 × 109 MBs/mL. A Sequoia 512 US system (Acuson, 
Siemens, Mountain View, CA, USA) with the 15L8w probe was used to perform contrast imaging at 12 
MHz along two planes close to the tumor’s maximal cross section and separated by 1 mm. The non-linear 
signals from the microbubbles were specifically detected with cadence contrast pulse sequencing (CPS). 
MB were injected as a bolus in the tail vein at 1mL/kg using a controlled system described in a previous 
publication (Dizeux et al. 2016) and a flow of 2 mL/min. Two perfusion parameters were then extracted 
from 60-s recordings using parameters assessed without model fitting (Barrois et al. 2013). The Time-Of-
Arrival (TOA) was calculated in 3 by 3 pixel regions based on the time point at which contrast agent 
intensity reached 90% of its maximum intensity in the region. If intensity remains below 3 times the noise 
standard deviation in a region, then the region is considered a non-perfused area. The Mean of Intensity 
(MoI) is the temporal average of the low-pass filtered intensity. Here, the MoI and TOA averaged over all 
pixels in all maps are reported. To describe the distribution of these parameters in each map, the average 
standard deviations for all measurements are also reported. The individual maps of the parameters were 
used to spatially compare DCE-US and tomography results. 
1.4 Statistical analysis 
Statistics on quantitative results were performed using Matlab. A global one-way ANOVA test was used 
to evaluate if the samples are from different populations with the same mean. A t-test was then 
performed to assess the difference between the results obtained in two groups. A p-value < 0.05 was 
considered to indicate a significant difference. 
RESULTS 
UFD-T was performed on all tumors to monitor their structural and functional development. Tumors 
were identified and segmented manually on the successive B Mode images acquired during UFD-T. From 
the same acquisitions, UFD-T reconstruction enabled the detection of blood vessels, consequently there 
was no need to co-register the tumor boundaries and the vascular network which were then fused directly 
for volume rendering (Figure 2a). 
The noninvasiveness and ease-of-use of the technique allowed longitudinal imaging of the tumor 
development across our 4 mice at Days 8, 12, 16 and 20 (Figure 2bErreur ! Source du renvoi introuvable.). 
However, 2 mice had to be euthanized before the end of the study as they met the endpoint criteria 
regarding tumor size. One mouse was also not imaged at Day 16 due to technical difficulties. Steady tumor 
growth was observed with tumor volume increasing from 11 ± 3.3 mm3 at Day 8 to 473 ± 188 mm3 at Day 
20 (68 ± 15 mm3 at Day 12 and 194 ± 104 mm3 at Day 16) as seen on Figure 2b. In addition, the 3D 
renderings clearly showed that the vasculature had a tendency to grow on the periphery rather than in 
the tumor core. The apparent smaller density of vessels of the caliber detected by ultrafast Doppler in the 
center of the tumor is consistent with the vascular architecture that has been previously reported for this 
type of tumor (3LL)(Dizeux et al. 2017). 
UFD-T 3D monitoring revealed the process involved in building the vascular architecture irrigating the 
tumor. These results demonstrated that, in our model, the tumor’s blood supply stemmed from pre-
existing blood vessels (Figure 3, Supplemental Video 1). Blood vessels were observed as a loose network 
around the early-stage tumor and did not appear to penetrate the tumor indicating that it was still mostly 
the normal vascular network already present in the skin. However, as the tumor volume increased, 
exceeding a few millimeters in diameter, sprouting of new vessels from existing surrounding blood vessels 
was seen. Between Day 12 and Day 16, the vascularization kept on growing developing into a more 
homogeneous network irrigating the whole tumor volume. Then, as a critical size was reached, a vascular 
void was observed in the center of the tumor surrounded by highly-perfused periphery with a dense and 
tortuous network (Supplemental Video 1). The precise delineation of vessels provided by UFD-T also made 
it possible to follow individual vessels in time. For example, a large pre-existing skin vessel was identified 
from one time point to the next as highlighted with a green line on Figure 3. From this particular vessel, it 
can be observed that at each stage new blood vessels are sprouting and forming ramifications leading to 
a global increase of the vascular network.  
The DCE-US results are reported in Table 2. The MoI and TOA averaged over all pixels are reported as 
a “spatial mean”. Distribution of these parameters in each map is reflected in the average standard 
deviations for all measurements reported as “spatial SD”. 
The four mice tend to follow similar trends. MoI increases from Day 8 to Day 12 while TOA decreases 
as the vascular networks grow. Then, as the tumor develops, these trends reverse. A particularly 
interesting aspect is the increase in standard deviations at later stages for both parameters reflecting the 
higher spatial heterogeneity of the vasculature. 
The evolution of the vascular network supplying the tumor seen on UFD-T volume renderings was also 
confirmed by parametric maps acquired at the same time points using DCE-US (Figure 4). Time of arrival 
(TOA) and Mean of Intensity (MoI) maps clearly depict the different steps of tumor vasculature 
development. Whereas MoI informs on perfusion density, TOA reflects the spatial hierarchy in terms of 
blood supply. Early on, the network is scattered and poorly ramified resulting in high TOA values with a 
dispersed distribution and low MoI except in the few pre-existing big vessels. Then, the vascular network 
grows leading to a decrease in TOA across the tumor. Higher overall MoI values are observed as well which 
is also in line with a more efficient, developing network. The tumor then reaches a critical size, and the 
blood vessels, mainly located at the periphery of the tumor, do not supply the center anymore, resulting 
in TOA and MoI maps with radial gradients. In the TOA map shown in Figure 4, two pixels located in the 
center of the tumor are displayed in black. They are considered as non-perfused because the intensity did 
not reach 3 times the noise standard deviation. In every case assessed in this study, the inhomogeneity 
seen on DCE-US maps was also observed in the distribution of blood vessels as assessed by UFD-T. 
Beyond the visual anatomic descriptive capabilities of UFD-T for tumor imaging, this new modality also 
enables quantitative assessment of the state of the tumor. In this paper we chose to explore the 
quantification capabilities of UFD-T by computing relevant anatomical parameters such as the length of 
vessels irrigating the tumor, their diameter and the tumor volume. We first quantified the growth of the 
vascular network of the tumor by calculating the length of blood vessel at the different stages of 
development (Figure 5). For data analysis, the results obtained at Day 16 and Day 20 were combined to 
get 4 measurements at each growth stage. In order to take into account that not all blood vessels are 
equivalent, we sorted them according to their diameter and computed the cumulative length per 
population of vessels gathered in 0.04mm-wide diameter bins (Figure 5.a). First, the total vascular length, 
calculated as the sum of all the bins, increases as the tumor grows showing a quick evolution from Day 8 
to Day 12 (208.6 ± 51.6 mm to 424.7 ± 99.6 mm, p < 0.01), and a slower pace from Day 12 to later time 
points (548.0 ± 156.1 mm, not significantly different). Interestingly, this inter-stage increase is seen across 
all diameters. For each stage of development, the repartition of the blood vessels according to their 
diameter follows an exponential tendency (R² > 0.93) that has been seen in previous studies (Hashizume 
et al. 2000; Junaid et al. 2017). The degree of growth is quantified finely according to the hierarchical 
position of the vessel in the vascular architecture: a large part of the network is represented in small 
vessels less than 200 μm in diameter (80% at Day 8, 79% at Day 12, and 74% at later stages). 
In addition, UFD-T results allowed us to quantify whether, beyond the obvious growth of the vascular 
network of the tumor, there is a structural change in the distribution of vessels in the vascular tree: does 
the tumor growth result in more big or small vessels? For this purpose, the cumulative length is 
represented not in millimeters but as a percentage of the total length of the network of each tumor (Figure 
5.b). The average value of this "distribution function" of the vessels length is shown by grouping the 4 
time points of the study. The specific results for each development stage are also displayed. These results 
indicate that, despite a strong growth of the tumor vascular network, the overall structure and ratio of 
the small vessels relative to the larger vessels remains generally the same during tumor growth. However, 
a slight difference can be observed. The relative length of vessels at Day 8 was higher than at later stages 
for vessels smaller than 160 µm (although not significantly) and lower between 160 and 250 µm (p = 0.02).  
Finally, the efficiency of the vascular network was investigated by correlating the cumulative length of 
vessels 𝜁 to the tumor volume and radius (Figure 6). It is reasonable to assume that in a given healthy 
tissue there is a relationship of proportionality between the volume of tissue considered and the length 
of the vascular network that irrigates it. Here, however, this is not the case and 𝜁 rather changes according 
to the radius of the tumor rather than to the volume. Thus, Figure 6a shows that 𝜁 normalized by the 
tumor volume dramatically decreases with the age of the tumor, which suggests a weakening of the tumor 
perfusion, whereas in the Figure 6.b, ζ normalized by the tumor radius exhibits quite similar trends across 
the 3 stages of development.  
DISCUSSION  
UFD-T is a novel imaging technique for quantitative 3D visualization of vasculature. In this study, 4 
ectopic tumors were imaged longitudinally over 13 days to provide various information on the 
development of their vascular tree. Three-dimensional UFD-T results showed the structural and functional 
organization of the growing tumors revealing not only a steady volume increase but also a tendency of 
the network to develop primarily in the periphery for this particular type of tumors (3LL)(Dizeux et al. 
2017). High-resolution individual vessel monitoring showed that the tumor vasculature stems from pre-
existing vessels. The quality of vascular structure reconstruction can be regarded as slightly inferior to that 
obtained in a previous study on the rat brain (Demené et al. 2016). This can be explained both because 
the vascular network of the tumor is intrinsically less organized than the rat brain vasculature, but also 
because motion artefacts are more important. Smaller vessels sprout as the tumor grows, irrigating the 
full tumor volume until a critical size is reached. The tumor core then generally lacks sufficient perfusion 
and ultimately becomes necrotic. Further analysis on vessel diameter and length confirmed the tumor 
functional evolution providing additional quantitative information on the vascular tree. As expected, the 
network increases over time with a large part constituted by small vessels at all stages. However, the 
vessel diameter distribution remains relatively constant throughout tumor growth in our model. This 
study also showed that vessel length seems to be more related to tumor radius than to volume leading to 
the perfusion becoming insufficient when critical mass is reached. UFD-T allowed a precise 3D description 
of the growth of the tumorous vascular tree through angiogenesis from preexisting vessels to a chaotic 
and weakly efficient network leading to areas of necrosis due to lack of nutriments and oxygenation.  
In current ultrasound imaging, parameters are typically evaluated in 2D imaging planes, generally as 
spatial means. However, solid tumor vascular distribution is often very heterogeneous both spatially and 
in terms of vessel diameter and flow rates (Gillies et al. 1999; Jain 1988). The precise characterization of 
tumor vasculature thus requires a 3D imaging technique providing both structural and functional 
information that is sensitive enough to assess vessels as small as a few hundred microns in diameter and 
flows as slow as 1 mm/s. In addition, 3D imaging is particularly important for longitudinal monitoring as it 
removes the variability in 2D imaging plane selection from one time point to another allowing single vessel 
analysis as shown in this work. Finally, functional imaging needs to be coupled with a reliable, co-
registered imaging technique such as B Mode imaging to identify where the vascular features are located. 
This study showed that UFD-T fits all the criteria to be a very useful tool for the monitoring of tumor 
vascular development through angiogenesis. In the future, the development of high frequency 3D probes 
and the electronics to drive them at ultrafast framerates will enable acquisition of volumic data without 
the need for time-consuming mechanical scanning.  
When looking at the relative distribution of the vessel diameter, a slight difference was observed with 
respect to the relative length of vessels at Day 8 which was higher than at later stages for vessels below 
160 µm and lower between 160 and 250 µm. It may be speculated that inflammation of the tumor 
occurring at later stages may have led to dilatation of very small vessels reflected by this translation 
towards the vessels of larger diameter. In further works, histology would be necessary to test this 
hypothesis and understand why only this range of vessels is concerned. 
Studies have shown that the vascular heterogeneity of tumors can be linked to disease progression 
and malignancy (Agrawal et al. 2009). Beyond a certain size, simple diffusion of oxygen to active tumor 
cells becomes inadequate, and the tumor needs to turn toward another way to sustain its growth. In the 
early 1990s, studies showed that hypoxia could induce expression of growth factors in tissue culture 
(Kourembanas et al. 1990; Shweiki et al. 1992). Investigation of the mechanism behind hypoxia-stimulated 
angiogenesis revealed the role of the Hypoxia-inducible factor-1 (HIF-1), a transcription factor responsible 
for cellular adaptive responses to hypoxia (Pugh and Ratcliffe 2003). Under hypoxic conditions, HIF-1 
induces the expression of various factors such as VEGF, inducing angiogenesis and protecting endothelial 
cells. In addition, HIF-1-regulated genes have been associated with resistance to chemotherapy, invasion, 
metastasis, and tumor malignant phenotypes. To date, extensive efforts have been devoted to 
understand the role of HIF-1 and hypoxia in tumor growth and resilience to treatment (Carmeliet et al. 
1998). In addition, Harada et al. (Harada et al. 2008) showed that the distance between HIF-1-active 
regions and the nearest tumor blood vessel correlates to the diameter of the vessel. In this context, UFD-
T could prove very useful to quantify vessel diameters and map their 3D distribution which could help to 
identify HIF-1-active regions, prone to angiogenesis. 
UFD-T would also greatly benefit therapy for efficiency evaluation, response assessment and 
treatment planning. For example, anti-angiogenic therapy could profit greatly from UFD-T not only to 
monitor the early effects on vascularization but also to improve treatment efficiency. Certain 
antiangiogenic agents have been seen to normalize the chaotic tumor vasculature increasing the efficacy 
of complementary therapies such as chemotherapy (Jain 2005). However, a careful schedule needs to be 
respected as the normalization is transitory. Imaging techniques such as UFD-T may identify this optimal 
window as well as provide information on the underlying mechanisms of vasculature normalization. The 
technique would thus be a crucial tool not only for cancer but also other diseases with abnormal 
vasculature such as psoriatic skin lesions and atherosclerotic plaques. 
Contrast imaging was performed in this work to validate UFD-T observations. DCE-US parameters 
confirmed the evolving characteristics of tumor development seen with UFD-T. TOA and MoI maps were 
calculated providing information on perfusion from the scattered sprouts stemming from a pre-existing 
vessel to the heterogeneous network with a weakly perfused central region reflected by a clear radial 
gradient on both DCE-US maps. However, some limits apply to the comparison resulting in slight 
differences between the results obtained with the two modalities. First of all, DCE-US is a 2D technique 
as it is currently performed. In this work, the corresponding plane in UFD-T was carefully found in the 3D 
volume based on the B-mode images acquired during both scans, but some variability remains possible. 
Second, as mentioned before, UFD-T spatial resolution is 100 µm with our parameters (emission 
frequency of 15 MHz) and it can detect flows as slow as 1 mm/s. However, a minimum number of red 
blood cells is required to get a signal. With DCE-US, the spatial resolution is lower (on the order of 200 
µm), but the technique can theoretically detect presence of very slow flows in vessels as small as a 
microbubble (1-3 µm in diameter) due to its sensitivity at the level of individual microbubbles. UFD-T can 
distinguish vessels that are very close to one another and precisely delineate the vasculature whereas 
DCE-US has the edge when it comes to very weak flows and smaller vessel detection such as tumor 
capillaries whose diameter is on the order of a few microns (Leunig et al. 1992). Thus, UFD-T vascular 
visualization can be completed using DCE-US detection of very poorly perfused areas. Finally, even though 
3D spatial resolution has been improved with UFD-T down to ~100µm, tumor vessels can be as small as a 
few µm with quasi-static flows. It may be possible that their diameter was overestimated and they were 
sorted in the 100µm bin in the graphs and for analysis.  
At the time this article was being written, 2D super resolution ultrasound using contrast agents as 
isolated ultrasound scatterers were starting to be used for 2D super-localised vascular imaging of tumors 
(Opacic et al. 2018) with very interesting quantification capabilities. The differences between the two 
studies has to be pointed out because they reveal two different approaches. We aimed at giving a 3D-
capable imaging technique that can achieve completion in a reasonable time with relevant quantitative 
data for angiogenesis monitoring. The time to achieve the complete 3D scan (with ~65 slices per volume 
and 18 orientations) is typically 15 to 20 minutes.  
With the technique described in the cited paper (Opacic et al), taking into the account the 40s per 
super resolved image acquisition time, building an equivalent 3D volume (with the same number of slices 
and orientation, which is a gross estimation of what would be needed) would take 13h. Therefore, 
contrast agent and UFD-T may ultimately be combined to perform super-resolution vascular imaging by 
using both increased concentration of micro-bubbles (which needs to remain high and relatively stable, 
using infusion of microbubbles with a syringe pump) and plane wave ultrafast imaging (Errico et al. 2015), 
in order to reduce the acquisition time. Two important issues are that super-resolution imaging is very 
sensitive to tissue motion which needs to be perfectly corrected as recently demonstrated (Foiret et al. 
2017; Hingot et al. 2017), and also that 3D fusion of 2D super-resolved images is still an open question 
because the out-of-plane dimension is not being super-resolved. 
This pilot study evaluates the potential of UFD-T in tumor development and anti-angiogenic 
monitoring. A complementary study in histology would be necessary to more thoroughly discuss the 
relevance of the curves of vessel length obtained from the UFD-T data: it is possible in microscopy to count 
the vessels and their relative proportion as a function of the diameter.  Hashimuze et al. (Hashizume et 
al. 2000) investigated the cause for the well-known leakiness of tumor vessels. Using fluorescence 
staining, immunohistochemistry as well as Scanning Electron Microscopy, they studied the characteristics 
of individual vessels including their diameter distribution. Interestingly, the curve obtained strongly 
resembles the power law observed here non-invasively with UFD-T (Figure 5). Additional structural 
parameters could also be accessed using UFD-T such as tortuosity and the degree of ramification. 
Tortuosity has been particularly investigated,  showing a positive correlation to tumor development, and 
it is one of the markers of vessel normalization resulting from antiangiogenic treatment (Gillies et al. 
1999).  
Beyond these structural markers, however, UFD-T can also give access to other perfusion parameters 
such as the axial blood flow speed in every pixel of a 3D UFD-T acquisition. Although this parameter was 
not calculated in this study due to the trade-off in framerate it requires, previous studies (Demené et al. 
2016) have shown that UFD-T can discriminate flows based on their speed using a bank of band-pass 
filters. As the orientation of the vessel is known in the 3-D space, it is even possible to estimate the true 
speed vector discriminating veins from arteries although diverging errors will apply for horizontal vessels.  
CONCLUSION 
UFD-T is a non-invasive 3D imaging technique capable of quantifying tissue vascularization in vivo. This 
study showed that UFD-T can give access to structural and functional information in tumors during a 
longitudinal follow-up revealing the specific stages of angiogenesis. The technique revealed that our 
model’s vasculature stems from pre-existing vessels and then sprouts quickly to perfuse the whole 
volume. When the tumor reaches a critical size, the core is no longer irrigated ultimately resulting in a 
necrotic core. UFD-T high-resolution allows the extraction of quantitative parameters such as the vessel 
diameter revealing a relatively constant size distribution throughout tumor growth in our model. UFD-T 
also showed that the vascular tree grew as a function of tumor radius rather than volume explaining the 
appearance of the necrotic central region. Heterogeneity is a typical trademark of tumor vascular 
development through angiogenesis leading to the necessity of a 3D technique to evaluate this aspect 
crucial to therapy for treatment monitoring, response assessment and treatment planning for optimal 
efficiency.  
 
TABLES 
Modality MRI CT (VCT) µCT Photoacoustics OCT(OFDI) 
Resolution ~100-500 µm ~50-200 µm ~30-200 µm ~50-100 µm 10 µm 
Penetration 
Depth 
No limit No limit No limit 1 cm 1 mm 
Acquisition 
time 
A few minutes 
to hours 
Tens of 
minutes 
Tens of 
minutes 
Tens of 
minutes 
Tens of 
minutes 
Need for 
contrast agent 
yes Yes yes no no 
Example 
     
Reference 
(Kobayashi et 
al. 2001) 
(Kiessling et al. 
2004) 
(Ehling et al. 
2014) 
(Laufer et al. 
2012) 
(Vakoc et al. 
2009) 
Table 1 Review of some of the tumor vascular imaging techniques in preclinical research in vivo. 
 
 Spatial mean Spatial SD 
Day MoI [a.u.] TOA [s] MoI [a.u.] TOA [s] 
8 79.7 ± 5.1 28.6 ± 8.7 2.2 ± 1.6 8.3 ± 3.7 
12 84.2 ± 3.7 19.0 ± 7.5 1.7 ± 1.0 8.0 ± 3.3 
16-20 75.6 ± 3.1 33.7 ± 10.0 7.1 ± 0.8 22.9 ± 11.0 
Table 2 DCE-US results for the 4 mice. The mean and Standard Deviation (SD) of the Mean of Intensity 
(MoI) and Time-Of-Arrival (TOA) are shown for the different stages. 
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FIGURE LIST 
 
Figure 1 Schematic representation of the experimental protocol from tumor implantation (left), to 
imaging using UFD-T (middle) and DCE-US (right). 
 Figure 2 a. Structural information given via UFD-T imaging: PW Doppler enables a 3D reconstruction of 
the tumor vascular 3D reconstruction (left image) whereas tissue images available before spatiotemporal 
filtering enables 3D segmentation of the tumor boundary (right image). Combined, they give a precise 
delineation of the vascular architecture inside and surrounding the tumor  b. The 12 UFD-T acquisitions 
realized on the 4 mice of the study, represented as a Volume rendering: the transparent blue volume is 
the segmented contour of the tumor, and in red is the vascular network reconstructed via UFD-T. Two 
mice were euthanized before the end of the 20 days, and the Day 16 acquisition of Mouse 3 was not 
conducted. Overall, UFD-T reconstruction shows a clear peripheral organization of the tumor 
vascularization. 
 Figure 3 Monitoring via UFD-T of one of the four tumors on 12 days, visualized via a Maximum intensity 
Projection (MIP) technique. Position of the tumor is depicted as a dashed blue line. Growth of the vascular 
network is easily observed. Highlighted in green, a skin pre-existing large vessel , at distance from the 
tumor at day 8, becomes a major supply vessel for the tumor at day 20 (white arrow indicates a visible 
branching at day 16 and 20). 
 Figure 4 Comparison of the 2D parametric description of the tumor using DCE-US and the vascular 
information obtained with UFD-T in the same location (slice selected in the 3D volume) for a tumor at 
different stages of development (top row at Day 8, middle row at Day 12 and bottom row at Day 20). DCE-
US Time of Arrival (left column) reflects the structural organization of the tumor vasculature when the 
Mean of Intensity (middle column) shows the level of perfusion. UFD-T Maximum Intensity Projection 
maps (right column) depicts the underlying vasculature which develops from a poorly ramified network 
to a more homogeneous tree. When the critical size is reached, the tumor core becomes very weakly 
perfused and the vasculature is then mainly located at the periphery. 
 Figure 5 a. Distribution of the blood vessels for 3 development stages in terms of cumulative length 𝜁 
plotted against the blood vessel diameters 𝜑, for 4 tumors in each development stage (8 days, 12 days, 
16 and 20 days). Each bin gathers the total cumulative length in mm of a population of vessels whose 
diameter is included between 𝜑 ± 𝜖, with 𝜖 = 0.02mm. Days 16 and 20 have been pooled to increase the 
number of individuals and because the difference of development at that stage was not significantly 
different (maximum size of the tumor is reached). b. Cumulative length 𝜁 normalized by the total length 
of the vascular network 𝜁0, plotted against the same categorization of diameter. Lines represent the 3 
stages of development, and the blue bars the average relative cumulative length across all tumors, 
whatever their development stage. For example, vessels with diameters between 0.08 and 0.16 mm 
represent on average ≈50% of the total length of the network at all stages of development studied. 
 Figure 6 a. Cumulative length normalized by the tumor volume  𝜁/𝑣𝑜𝑙𝑢𝑚𝑒𝑡𝑢𝑚𝑜𝑟 plotted against the 
vessels diameter 𝜑. Once again each point (bins have been changed to points for the sake of readability) 
gathers the total cumulative length in mm of a population of vessels whose diameter is included 
between 𝜑 ± 𝜖, with 𝜖 = 0.02 mm, and day 16 and day 20 have been gathered in one group. b. Same 
graph, but the cumulative length 𝜁 has been normalized by a scale proportional to the tumor radius, 
estimated as the cubic root of the tumor volume. 
